Who
Peter Behner
Director
Company insider
Files Form 4 as: Director, MiNK Therapeutics.
In numbers
- Trades disclosed
- 25
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 9 Mar 2022
- Last trade
- 1 Sep 2026
- Last filed
- 2 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 2 Sep 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K1,485 at $10.95 | filing |
| 1 Sep 2026filed 2 Sep 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K1,485 at $10.95 | filing |
| 1 Jun 2026filed 2 Jun 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K1,313 at $12.38 | filing |
| 1 Jun 2026filed 2 Jun 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K1,313 at $12.38 | filing |
| 2 Mar 2026filed 2 Jun 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K1,491 at $10.90 | filing |
| 2 Mar 2026filed 2 Jun 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K1,491 at $10.90 | filing |
| 2 Jan 2026filed 6 Jan 2026 | INKT MiNK Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,395 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | INKT MiNK Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,395 at $0.00 | filing |
| 1 Dec 2025filed 3 Dec 2025 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K1,466 at $11.09 | filing |
| 9 Sep 2025filed 11 Sep 2025 | INKT MiNK Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,225 at $0.00 | filing |
| 2 Sep 2025filed 3 Sep 2025 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K1,173 at $13.86 | filing |
| 2 Jun 2025filed 4 Jun 2025 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K2,267 at $7.17 | filing |
| 3 Mar 2025filed 5 Mar 2025 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $16K1,849 at $8.79 | filing |
| 1 Dec 2024filed 3 Dec 2024 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $15K20,987 at $0.73 | filing |
| 3 Sep 2024filed 5 Sep 2024 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $15K18,753 at $0.82 | filing |
| 3 Jun 2024filed 5 Jun 2024 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $15K15,454 at $0.99 | filing |
| 1 Mar 2024filed 5 Mar 2024 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $15K16,185 at $0.95 | filing |
| 1 Dec 2023filed 5 Dec 2023 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $15K14,784 at $1.04 | filing |
| 1 Sep 2023filed 6 Sep 2023 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $15K10,531 at $1.46 | filing |
| 14 Jun 2023filed 16 Jun 2023 | INKT MiNK Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.